Back

Time-restricted feeding exacerbates liver fibrosis by promoting BDH1-mediated ketolysis in hepatic stellate cells.

Lemnitzer, P.; Pinzani, M.; Pan, C.; Mingzhe, W.

2026-03-24 cell biology
10.64898/2026.03.21.712927 bioRxiv
Show abstract

Time-restricted feeding (TRF) is widely considered metabolically beneficial, yet its impact on chronic liver disease progression remains poorly defined. This study investigates the effects of TRF on liver fibrogenesis. Using carbon tetrachloride (CCl4)-induced, bile duct ligation (BDL)-induced, and choline-deficient, L-amino acid-defined high-fat diet (CDAHFD)-induced murine models of liver fibrosis, we demonstrate that TRF consistently exacerbates fibrotic injury. Mechanistically, TRF induces the systemic elevation of the ketone body {beta}-hydroxybutyrate (BHB). We identify the ketolytic enzyme 3-hydroxybutyrate dehydrogenase 1 (BDH1) as a critical mediator of this process within hepatic stellate cells (HSCs). BDH1 expression is markedly upregulated in activated HSCs, enabling these cells to metabolize BHB. This BDH1-dependent ketolysis redirects BHB-derived carbons into the tricarboxylic acid cycle, supplying acetyl-CoA and citrate to drive de novo lipogenesis and support a profibrogenic metabolic state. Both the genetic ablation of Bdh1 specifically in HSCs and the inhibition of hepatic ketogenesis successfully abolished the pro-fibrotic effects of TRF and exogenous BHB administration. Conversely, exogenous BHB alone was sufficient to recapitulate the exacerbated fibrotic phenotype observed with TRF. These findings reveal a context-dependent, detrimental role for TRF during chronic liver injury, driven by BDH1-mediated metabolic reprogramming in HSCs. Consequently, dietary interventions that elevate systemic ketone bodies should be approached with caution in the setting of active liver fibrosis.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
Molecular Metabolism
105 papers in training set
Top 0.1%
17.0%
2
Gastroenterology
40 papers in training set
Top 0.2%
9.8%
3
Cellular and Molecular Gastroenterology and Hepatology
41 papers in training set
Top 0.1%
7.0%
4
JCI Insight
241 papers in training set
Top 0.6%
6.2%
5
Developmental Cell
168 papers in training set
Top 3%
6.1%
6
eLife
5422 papers in training set
Top 15%
6.1%
50% of probability mass above
7
Cell Reports
1338 papers in training set
Top 13%
3.8%
8
Nature Communications
4913 papers in training set
Top 41%
3.5%
9
Cell Metabolism
49 papers in training set
Top 0.5%
3.5%
10
Nature Metabolism
56 papers in training set
Top 0.6%
3.5%
11
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 23%
3.2%
12
Hepatology Communications
21 papers in training set
Top 0.2%
2.7%
13
Hepatology
18 papers in training set
Top 0.2%
1.7%
14
Journal of Hepatology
18 papers in training set
Top 0.2%
1.6%
15
EMBO reports
136 papers in training set
Top 3%
1.6%
16
Frontiers in Cell and Developmental Biology
218 papers in training set
Top 5%
1.6%
17
The FASEB Journal
175 papers in training set
Top 2%
0.9%
18
Journal of Clinical Investigation
164 papers in training set
Top 5%
0.9%
19
Science Advances
1098 papers in training set
Top 27%
0.9%
20
Cell Reports Medicine
140 papers in training set
Top 7%
0.8%
21
Arteriosclerosis, Thrombosis, and Vascular Biology
65 papers in training set
Top 2%
0.8%
22
Journal of Lipid Research
35 papers in training set
Top 0.6%
0.7%
23
Life Science Alliance
263 papers in training set
Top 3%
0.6%
24
Stem Cells Translational Medicine
11 papers in training set
Top 0.3%
0.6%
25
Cell Chemical Biology
81 papers in training set
Top 4%
0.6%